Technical Advances for the Clinical Genomic Evaluation of Sudden Cardiac Death: Verification of Next-Generation Sequencing Panels for Hereditary Cardiovascular Conditions Using Formalin-Fixed Paraffin-Embedded Tissues and Dried Blood Spots

Circulation: Cardiovascular Genetics

Volumn 10, Issue 6, 2017, Pages

  Baudhuin, Linnea M ^a   Leduc, Charles ^a   Train, Laura J ^a   Avula, Rajeswari ^a   Kluge, Michelle L ^a   Kotzer, Katrina E ^a   Lin, Peter T ^a   Ackerman, Michael J ^b,d   Maleszewski, Joseph J ^a,c  

^a MAYO CLINIC   (United States)

^b Department of Cardiovascular Diseases ^*  (United States)

^c Division of Pediatric Cardiology   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

Author keywords

autopsy; cardiomyopathies; genetic testing; genotype; paraffin

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FORMALDEHYDE; NUCLEIC ACID; PARAFFIN;

ACCURACY; ADULT; AGED; ARTICLE; AUTOPSY; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CASE REPORT; CLINICAL ARTICLE; CLINICAL EVALUATION; DNA DETERMINATION; DRIED BLOOD SPOT TESTING; EXTRACORPOREAL OXYGENATION; FEMALE; GENETIC ASSOCIATION; GENETIC DISORDER; GENOMICS; GENOTYPE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MIDDLE AGED; MUSCLE RESECTION; NEXT GENERATION SEQUENCING; NOONAN SYNDROME; PHENOTYPE; PRIORITY JOURNAL; PROSTHETIC VALVE ENDOCARDITIS; SENSITIVITY AND SPECIFICITY; SEPSIS; SUDDEN CARDIAC DEATH;

EID: 85038623324     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.117.001844     Document Type: Article

References (28)

1. Deo R, Albert CM. Epidemiology and genetics of sudden cardiac death. Circulation. 2012;125:620-637. doi: 10. 1161/CIRCULATIONAHA. 111. 023838.
2. Basso C, Aguilera B, Banner J, Cohle S, d'Amati G, de Gouveia RH, et al. Guidelines for autopsy investigation of sudden cardiac death: 2017 update from the Association for European Cardiovascular Pathology. Virchows Arch (2017). doi: 10. 1007/s00428-017-2221-0.
3. Anderson JH, Tester DJ, Will ML, Ackerman MJ. Whole-exome molecular autopsy after exertion-related sudden unexplained death in the young. Circ Cardiovasc Genet. 2016;9:259-265. doi: 10. 1161/CIRCGENETICS. 115. 001370.
4. Methner DN, Scherer SE, Welch K, Walkiewicz M, Eng CM, Belmont JW, et al. Postmortem genetic screening for the identification, verification, and reporting of genetic variants contributing to the sudden death of the young. Genome Res. 2016;26:1170-1177. doi: 10. 1101/gr. 195800. 115.
5. Tester DJ, Ackerman MJ. Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. J Am Coll Cardiol. 2007;49:240-246. doi: 10. 1016/j. jacc. 2006. 10. 010.
6. Middleton OB, Demo E, Honeywell C, Jentzen J, Miller F, Pinckard JK, et al. National Association of Medical Examiners Position Paper: retaining postmortem samples for genetic testing. Acad Forensic Pathol. 2013;3:191-194.
7. Ackerman MJ. Genetic purgatory and the cardiac channelopathies: exposing the variants of uncertain/unknown significance issue. Heart Rhythm. 2015;12:2325-2331. doi: 10. 1016/j. hrthm. 2015. 07. 002.
8. Giannini C, Oelkers MM, Edwards WD, Aubry MC, Muncil MM, Mohamud KH, et al. Maintaining clinical tissue archives and supporting human research: challenges and solutions. Arch Pathol Lab Med. 2011;135:347-353. doi: 10. 1043/2010-0044-SA. 1.
9. Hykin SM, Bi K, McGuire JA. Fixing formalin: a method to recover genomic-scale DNA sequence data from formalin-fixed museum specimens using high-throughput sequencing. PLoS One. 2015;10:e0141579. doi: 10. 1371/journal. pone. 0141579.
10. Carturan E, Tester DJ, Brost BC, Basso C, Thiene G, Ackerman MJ. Postmortem genetic testing for conventional autopsy-negative sudden unexplained death: an evaluation of different DNA extraction protocols and the feasibility of mutational analysis from archival paraffin-embedded heart tissue. Am J Clin Pathol. 2008;129:391-397. doi: 10. 1309/ VLA7TT9EQ05FFVN4.
11. Cock PJ, Fields CJ, Goto N, Heuer ML, Rice PM. The Sanger FASTQ file format for sequences with quality scores, and the Solexa/Illumina FASTQ variants. Nucleic Acids Res. 2010;38:1767-1771. doi: 10. 1093/ nar/gkp1137.
12. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al; 1000 Genome Project Data Processing Subgroup. The Sequence Alignment/ Map format and SAMtools. Bioinformatics. 2009;25:2078-2079. doi: 10. 1093/bioinformatics/btp352.
13. Pathologists CoA. All Common Checklist. 2012. http://www. pathologieonline. de/wordpress/wp-content/uploads/2012/11/laboratory-general- checklist. pdf. Accessed November 13, 2017.
14. Pathologists CoA. Molecular Pathology Checklist. 2012. http://www. cap. org/apps/docs/education/OnlineCourseContent/2012/LAP/Resources/ Checklists/MOL09252012. pdf. Accessed November 13, 2017.
15. Health NYSDo. New York State Department of Health Oncology-Molecular and Cellular Tumor Markers: Next Generation Sequencing (NGS) Guidelines for Somatic Genetic Variant Detection. 2012. https://www. wadsworth. org/sites/default/files/WebDoc/Updated%20NextGen%20 Seq%20ONCO-Guidelines-032016. pdf. Accessed November 13, 2017.
16. Baudhuin LM, Lagerstedt SA, Klee EW, Fadra N, Oglesbee D, Ferber MJ. Confirming variants in next-generation sequencing panel testing by Sanger sequencing. J Mol Diagn. 2015;17:456-461. doi: 10. 1016/j. jmoldx. 2015. 03. 004.
17. Gargis AS, Kalman L, Berry MW, Bick DP, Dimmock DP, Hambuch T, et al. Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat Biotechnol. 2012;30:1033-1036. doi: 10. 1038/ nbt. 2403.
18. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405-424. doi: 10. 1038/gim. 2015. 30.
19. Alders M, Jongbloed R, Deelen W, van den Wijngaard A, Doevendans P, Ten Cate F, et al. The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands. Eur Heart J. 2003;24:1848-1853.
20. Maron BJ, Niimura H, Casey SA, Soper MK, Wright GB, Seidman JG, et al. Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Am Coll Cardiol. 2001;38:315-321.
21. Marston S, Copeland O, Jacques A, Livesey K, Tsang V, McKenna WJ, et al. Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency. Circ Res. 2009;105:219-222. doi: 10. 1161/CIRCRESAHA. 109. 202440.
22. Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna W, et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med. 1998;338:1248-1257. doi: 10. 1056/NEJM199804303381802.
23. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011;8:1308-1339. doi: 10. 1016/j. hrthm. 2011. 05. 020.
24. Van Driest SL, Ellsworth EG, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy. Circulation. 2003;108:445-451. doi: 10. 1161/01. CIR. 0000080896. 52003. DF.
25. Pandit B, Sarkozy A, Pennacchio LA, Carta C, Oishi K, Martinelli S, et al. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet. 2007;39:1007-1012. doi: 10. 1038/ng2073.
26. Ganesh A, Smith C, Chan W, Unger S, Quercia N, Godfrey M, et al. Immunohistochemical evaluation of conjunctival fibrillin-1 in Marfan syndrome. Arch Ophthalmol. 2006;124:205-209. doi: 10. 1001/archopht. 124. 2. 205.
27. Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47:476-485. doi: 10. 1136/jmg. 2009. 072785.
28. Tester DJ, Medeiros-Domingo A, Will ML, Haglund CM, Ackerman MJ. Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing. Mayo Clin Proc. 2012;87:524-539. doi: 10. 1016/j. mayocp. 2012. 02. 017.